Rockingstone Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Sell |
4,038
-285
| -7% | -$36.1K | 0.27% | 80 |
|
|
2025
Q1 | $553K | Sell |
4,323
-1,740
| -29% | -$223K | 0.25% | 80 |
|
|
2024
Q4 | $802K | Sell |
6,063
-2,217
| -27% | -$293K | 0.35% | 68 |
|
|
2024
Q3 | $1.21M | Buy |
8,280
+20
| +0.2% | +$2.91K | 0.59% | 52 |
|
|
2024
Q2 | $1.13M | Sell |
8,260
-50
| -0.6% | -$6.86K | 0.58% | 54 |
|
|
2024
Q1 | $1.14M | Sell |
8,310
-85
| -1% | -$11.7K | 0.59% | 61 |
|
|
2023
Q4 | $1.14M | Buy |
8,395
+555
| +7% | +$75.4K | 0.64% | 57 |
|
|
2023
Q3 | $959K | Buy |
7,840
+589
| +8% | +$72K | 0.53% | 59 |
|
|
2023
Q2 | $921K | Hold |
7,251
| – | – | 0.52% | 61 |
|
|
2023
Q1 | $937K | Sell |
7,251
-518
| -7% | -$66.9K | 0.57% | 61 |
|
|
2022
Q4 | $1.02M | Buy |
+7,769
| New | +$1.02M | 0.76% | 55 |
|